You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
C.H. Robinson Worldwide, Inc. (CHRW) - free report >>
Kinross Gold Corporation (KGC) - free report >>
Mercury General Corporation (MCY) - free report >>
Image: Bigstock
New Strong Buy Stocks for August 5th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Kinross Gold Corporation (KGC - Free Report) : This gold mining company has seen the Zacks Consensus Estimate for its current year earnings increasing 11.8% over the last 60 days.
Kinross Gold Corporation Price and Consensus
Kinross Gold Corporation price-consensus-chart | Kinross Gold Corporation Quote
Mercury General Corporation (MCY - Free Report) : This auto insurance company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.3% over the last 60 days.
Mercury General Corporation Price and Consensus
Mercury General Corporation price-consensus-chart | Mercury General Corporation Quote
GeneDx Holdings Corp. (WGS - Free Report) : This genomic diagnostics company has seen the Zacks Consensus Estimate for its current year earnings increasing 18.5% over the last 60 days.
GeneDx Holdings Corp. Price and Consensus
GeneDx Holdings Corp. price-consensus-chart | GeneDx Holdings Corp. Quote
C.H. Robinson Worldwide, Inc. (CHRW - Free Report) : This freight transportation company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.9% over the last 60 days.
C.H. Robinson Worldwide, Inc. Price and Consensus
C.H. Robinson Worldwide, Inc. price-consensus-chart | C.H. Robinson Worldwide, Inc. Quote
Fulcrum Therapeutics, Inc. (FULC - Free Report) : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 52.4% over the last 60 days.
Fulcrum Therapeutics, Inc. Price and Consensus
Fulcrum Therapeutics, Inc. price-consensus-chart | Fulcrum Therapeutics, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.